- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5355 - Non-condensed oxazines containing further heterocyclic rings
Patent holdings for IPC class A61K 31/5355
Total number of patents in this class: 660
10-year publication summary
|
35
|
34
|
35
|
46
|
40
|
34
|
31
|
49
|
38
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4494 |
28 |
| F. Hoffmann-La Roche AG | 7847 |
23 |
| Hoffmann-La Roche Inc. | 3726 |
17 |
| Recurium IP Holdings, LLC | 127 |
16 |
| Novartis AG | 10338 |
13 |
| Amgen Inc. | 4383 |
13 |
| Gilead Sciences, Inc. | 2207 |
13 |
| Bristol-myers Squibb Company | 4789 |
12 |
| Vitae Pharmaceuticals, Inc. | 87 |
11 |
| Shionogi & Co., Ltd. | 866 |
10 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
10 |
| Siena Biotech S.p.A. | 33 |
9 |
| Merck Patent GmbH | 5669 |
8 |
| The Trustees of the University of Pennsylvania | 4403 |
8 |
| Celgene Corporation | 1392 |
8 |
| Janssen Pharmaceutica N.V. | 3213 |
7 |
| Allergan, Inc. | 2198 |
6 |
| Takeda Pharmaceutical Company Limited | 2718 |
6 |
| Vanderbilt University | 1991 |
6 |
| AstraZeneca AB | 2830 |
5 |
| Other owners | 431 |